speb/financial-data huggingface dataset:
CRON.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -797000.00
CRON.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 82682000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Goodwill: 1033000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 27737000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 23332000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 207240000.00
CRON.TO income_statement (annual, 2022-12-31) — Gross Profit: 15436000.00
CRON.TO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 3493000.00
CRON.TO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 177000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Income Tax Payable: 32956000.00
CRON.TO income_statement (annual, 2022-12-31) — Interest Expense: 13000.00
CRON.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 13000.00
CRON.TO income_statement (annual, 2022-12-31) — Interest Income: 22514000.00
CRON.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 22514000.00
CRON.TO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 0.00
CRON.TO balance_sheet (annual, 2022-12-31) — Inventory: 37559000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 1143885000.00
CRON.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1842000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 49000000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 89748000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 18755000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Land And Improvements: 2556000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Loans Receivable: 8890000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 2546000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2546000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 18755000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 24475000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Minority Interest: -2921000.00
CRON.TO income_statement (annual, 2022-12-31) — Minority Interests: 0.00
CRON.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
CRON.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 2286000.00
CRON.TO income_statement (annual, 2022-12-31) — Net Income: -168734000.00
CRON.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -168734000.00
CRON.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -155178000.00
CRON.TO income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: -13556000.00
CRON.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -168734000.00
CRON.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -155178000.00
CRON.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -168734000.00
CRON.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -168734000.00
CRON.TO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -1581000.00
CRON.TO income_statement (annual, 2022-12-31) — Net Interest Income: 22514000.00
CRON.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -2508000.00
CRON.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 22514000.00
CRON.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -2897000.00
CRON.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 5314000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Net PPE: 62830000.00
CRON.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -3451000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1116148000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 0.00
CRON.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 0.00
CRON.TO balance_sheet (annual, 2022-12-31) — Non Current Note Receivables: 72345000.00
CRON.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: -49351000.00
CRON.TO income_statement (annual, 2022-12-31) — Normalized Income: -124247445.70
CRON.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -88948000.00
CRON.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -29627000.00
CRON.TO income_statement (annual, 2022-12-31) — Operating Income: -104390000.00
CRON.TO income_statement (annual, 2022-12-31) — Operating Revenue: 109301000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 380575403.00
CRON.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 7106000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 15000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -797000.00
CRON.TO income_statement (annual, 2022-12-31) — Other Gand A: 67674000.00
CRON.TO income_statement (annual, 2022-12-31) — Other Income Expense: -39127000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 26704000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Other Investments: 21993000.00
CRON.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 1294000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 193000.00
CRON.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -324000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Other Properties: 2273000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 3298000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 113077000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Payables: 48635000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 66771000.00
CRON.TO income_statement (annual, 2022-12-31) — Pretax Income: -121003000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Properties: 0.00
CRON.TO cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: -662000.00
CRON.TO cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -1581000.00
CRON.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -271378000.00
CRON.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -3451000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 8410000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Receivables: 37770000.00
CRON.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 64158000.00
CRON.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 13122000.00
CRON.TO income_statement (annual, 2022-12-31) — Research And Development: 13131000.00
CRON.TO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 3545000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: 490682000.00
CRON.TO income_statement (annual, 2022-12-31) — Salaries And Wages: 15008000.00
CRON.TO cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
CRON.TO cash_flow (annual, 2022-12-31) — Sale Of Investment: 268870000.00
CRON.TO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 18046000.00
CRON.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 100728000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Share Issued: 380575403.00
CRON.TO income_statement (annual, 2022-12-31) — Special Income Charges: -68430000.00
CRON.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 15115000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1143885000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1116148000.00
CRON.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -10986445.70
CRON.TO income_statement (annual, 2022-12-31) — Tax Provision: 34175000.00
CRON.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
CRON.TO balance_sheet (annual, 2022-12-31) — Total Assets: 1213009000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 1143885000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Total Debt: 3876000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1140964000.00
CRON.TO income_statement (annual, 2022-12-31) — Total Expenses: 191139000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 72045000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 252853000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 3929000.00
CRON.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -111428000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 37088000.00
CRON.TO income_statement (annual, 2022-12-31) — Total Unusual Items: -41917000.00
CRON.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -41917000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 0.00
CRON.TO balance_sheet (annual, 2022-12-31) — Work In Process: 15646000.00
CRON.TO balance_sheet (annual, 2022-12-31) — Working Capital: 892040000.00
CRON.TO income_statement (annual, 2022-12-31) — Write Off: 61392000.00
CRON.TO income_statement (annual, 2023-12-31) — +Operating Expense: 91819000.00
CRON.TO income_statement (annual, 2023-12-31) — +Total Revenue: 87241000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 12130000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 13984000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Accrued Interest Receivable: 10012000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -139770000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 48449000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -3000.00
CRON.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 26921000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 0.00
CRON.TO balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 25650000.00
CRON.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 380964739.00
CRON.TO income_statement (annual, 2023-12-31) — Basic EPS: -0.19
CRON.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 764644000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 168498000.00
CRON.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -3423000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 2553000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 662174000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 669291000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 861528000.00
CRON.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -1030000.00
CRON.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -59499000.00
CRON.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -42835000.00
CRON.TO cash_flow (annual, 2023-12-31) — Change In Account Payable: -773000.00
CRON.TO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 5160000.00
CRON.TO cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: -33104000.00
CRON.TO cash_flow (annual, 2023-12-31) — Change In Inventory: 7399000.00
CRON.TO cash_flow (annual, 2023-12-31) — Change In Payable: -33877000.00
CRON.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -28717000.00
CRON.TO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 1437000.00
CRON.TO cash_flow (annual, 2023-12-31) — Change In Receivables: -6587000.00
CRON.TO cash_flow (annual, 2023-12-31) — Change In Tax Payable: -33104000.00
CRON.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: -26468000.00
CRON.TO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 9206000.00
CRON.TO cash_flow (annual, 2023-12-31) — Changes In Cash: -103364000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Common Stock: 662174000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1099571000.00
CRON.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
CRON.TO balance_sheet (annual, 2023-12-31) — Construction In Progress: 3269000.00
CRON.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 75332000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 16041000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Current Assets: 933306000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 994000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 994000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 41399000.00
CRON.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 8110000.00
CRON.TO income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 5044000.00
CRON.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 8110000.00
CRON.TO income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 5044000.00
CRON.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 380964739.00
CRON.TO income_statement (annual, 2023-12-31) — Diluted EPS: -0.19
CRON.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -73963000.00
CRON.TO cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 1642000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 373000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Dueto Related Parties Non Current: 1003000.00
CRON.TO income_statement (annual, 2023-12-31) — EBIT: -79910000.00
CRON.TO income_statement (annual, 2023-12-31) — EBITDA: -71800000.00
CRON.TO income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 1583000.00
CRON.TO cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 0.00
CRON.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 8011000.00
CRON.TO cash_flow (annual, 2023-12-31) — End Cash Position: 669291000.00
CRON.TO income_statement (annual, 2023-12-31) — Excise Taxes: 33029000.00
CRON.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -1030000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Finished Goods: 14819000.00
CRON.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: -46258000.00
CRON.TO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 10513000.00
CRON.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00
CRON.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -19366000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 20678000.00
CRON.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 58231000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Goodwill: 1057000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 22135000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 13987000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 200594000.00
CRON.TO income_statement (annual, 2023-12-31) — Gross Profit: 11909000.00
CRON.TO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 3366000.00
CRON.TO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 33013000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Income Tax Payable: 64000.00
CRON.TO income_statement (annual, 2023-12-31) — Interest Income: 51235000.00
CRON.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 51235000.00
CRON.TO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 0.00
CRON.TO balance_sheet (annual, 2023-12-31) — Inventory: 30495000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 1099571000.00
CRON.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -59499000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 25650000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Investments And Advances: 54739000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 19488000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Land And Improvements: 2764000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Loans Receivable: 5541000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1559000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1559000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 19488000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 24707000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Minority Interest: -3447000.00
CRON.TO income_statement (annual, 2023-12-31) — Minority Interests: 590000.00
CRON.TO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CRON.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
CRON.TO cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 7324000.00
CRON.TO income_statement (annual, 2023-12-31) — Net Income: -73963000.00
CRON.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -73963000.00
CRON.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -70439000.00
CRON.TO income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -4114000.00
CRON.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -73963000.00
CRON.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -69849000.00
CRON.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -74553000.00
CRON.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -74553000.00
CRON.TO cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -918000.00
CRON.TO income_statement (annual, 2023-12-31) — Net Interest Income: 51235000.00
CRON.TO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -75409000.00
CRON.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 51235000.00
CRON.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1030000.00
CRON.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 17691000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Net PPE: 60824000.00
CRON.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2505000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1077436000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 226000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 181000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 226000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 181000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Non Current Note Receivables: 69036000.00
CRON.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: -24194000.00
CRON.TO income_statement (annual, 2023-12-31) — Normalized Income: -24330273.89
CRON.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -42835000.00
CRON.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 17837000.00
CRON.TO income_statement (annual, 2023-12-31) — Operating Income: -79910000.00
CRON.TO income_statement (annual, 2023-12-31) — Operating Revenue: 120270000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 381298853.00
CRON.TO balance_sheet (annual, 2023-12-31) — Other Current Assets: 5405000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 102000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 20678000.00
CRON.TO income_statement (annual, 2023-12-31) — Other Gand A: 49475000.00
CRON.TO income_statement (annual, 2023-12-31) — Other Income Expense: -44994000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 21078000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Other Investments: 9601000.00
CRON.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -1923000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 45000.00
CRON.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 1029000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Other Properties: 1356000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Other Receivables: 6341000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 192237000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Payables: 24262000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 40303000.00
CRON.TO income_statement (annual, 2023-12-31) — Pretax Income: -73669000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Properties: 0.00
CRON.TO income_statement (annual, 2023-12-31) — Provision For Doubtful Accounts: 0.00
CRON.TO cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -1528000.00
CRON.TO cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -918000.00
CRON.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -608247000.00
CRON.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -2505000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Raw Materials: 5083000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Receivables: 35878000.00
CRON.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 72266000.00
CRON.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 8110000.00
CRON.TO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
CRON.TO income_statement (annual, 2023-12-31) — Research And Development: 5843000.00
CRON.TO income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 1524000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: 416719000.00
CRON.TO income_statement (annual, 2023-12-31) — Salaries And Wages: 8756000.00
CRON.TO cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
CRON.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 532838000.00
CRON.TO income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 22701000.00
CRON.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 80932000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Share Issued: 381298853.00
CRON.TO income_statement (annual, 2023-12-31) — Special Income Charges: -28240000.00
CRON.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 8769000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1099571000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1077436000.00
CRON.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -2087273.89
CRON.TO income_statement (annual, 2023-12-31) — Tax Provision: -3230000.00
CRON.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.04
CRON.TO balance_sheet (annual, 2023-12-31) — Total Assets: 1140266000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 1099571000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Total Debt: 2553000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1096124000.00
CRON.TO income_statement (annual, 2023-12-31) — Total Expenses: 167151000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 44142000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 206960000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2743000.00
CRON.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -84800000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 11759000.00
CRON.TO income_statement (annual, 2023-12-31) — Total Unusual Items: -47606000.00
CRON.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -47606000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 0.00
CRON.TO balance_sheet (annual, 2023-12-31) — Work In Process: 10593000.00
CRON.TO balance_sheet (annual, 2023-12-31) — Working Capital: 891907000.00
CRON.TO income_statement (annual, 2023-12-31) — Write Off: 23350000.00
CRON.TO balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 51523000.00
CRON.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 382285589.00
CRON.TO income_statement (quarterly, 2024-09-30) — Basic EPS: 0.02
CRON.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 385984407.00
CRON.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.02
CRON.TO cash_flow (quarterly, 2024-09-30) — Dividends Received Cfi: 0.00
CRON.TO balance_sheet (quarterly, 2024-09-30) — Dueto Related Parties Current: 0.00
CRON.TO income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: -10422000.00
CRON.TO balance_sheet (quarterly, 2024-09-30) — Investmentsin Associatesat Cost: 0.00
CRON.TO balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 0.00
CRON.TO income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 0.00
CRON.TO cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 6000.00
CRON.TO balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 192000.00
CRON.TO balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 130000.00
CRON.TO income_statement (annual, 2024-12-31) — +Operating Expense: 84747000.00
CRON.TO income_statement (annual, 2024-12-31) — +Total Revenue: 117615000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 16973000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 15462000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 8690000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -133397000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -7000.00
CRON.TO balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -7000.00
CRON.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 42000000.00
CRON.TO cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
CRON.TO balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 8112000.00
CRON.TO balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 8112000.00
CRON.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 382058056.00
CRON.TO income_statement (annual, 2024-12-31) — Basic EPS: 0.11
CRON.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 669291000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 192059000.00
CRON.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -13154000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 2018000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 669879000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 858805000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 858805000.00
CRON.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -1231000.00
CRON.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 175149000.00
CRON.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 18843000.00
CRON.TO cash_flow (annual, 2024-12-31) — Change In Account Payable: -7449000.00
CRON.TO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 2840000.00
CRON.TO cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: -93000.00
CRON.TO cash_flow (annual, 2024-12-31) — Change In Inventory: 7417000.00
CRON.TO cash_flow (annual, 2024-12-31) — Change In Payable: -7542000.00
CRON.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -4702000.00
CRON.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -512000.00
CRON.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -2514000.00
CRON.TO cash_flow (annual, 2024-12-31) — Change In Tax Payable: -93000.00
CRON.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: -311000.00
CRON.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -917000.00
CRON.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 192761000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Common Stock: 669879000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1064063000.00
CRON.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
CRON.TO balance_sheet (annual, 2024-12-31) — Construction In Progress: 28710000.00
CRON.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 92417000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 19822000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Current Assets: 936113000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1025000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1025000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 49700000.00
CRON.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 9336000.00
CRON.TO income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 3701000.00
CRON.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 9336000.00
CRON.TO income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 3701000.00
CRON.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 385557002.00
CRON.TO income_statement (annual, 2024-12-31) — Diluted EPS: 0.11
CRON.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 41080000.00
CRON.TO cash_flow (annual, 2024-12-31) — Dividends Received Cfi: 0.00
CRON.TO cash_flow (quarterly, 2024-12-31) — Dividends Received Cfi: 0.00
CRON.TO balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 0.00
CRON.TO balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Current: 0.00
CRON.TO balance_sheet (annual, 2024-12-31) — Dueto Related Parties Non Current: 1073000.00
CRON.TO income_statement (annual, 2024-12-31) — EBIT: -59549000.00
CRON.TO income_statement (annual, 2024-12-31) — EBITDA: -50213000.00
CRON.TO income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 34834000.00
CRON.TO income_statement (quarterly, 2024-12-31) — Earnings From Equity Interest: 0.00
CRON.TO cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -32469000.00
CRON.TO cash_flow (quarterly, 2024-12-31) — Earnings Losses From Equity Investments: 0.00
CRON.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -3247000.00
CRON.TO cash_flow (annual, 2024-12-31) — End Cash Position: 858805000.00
CRON.TO income_statement (annual, 2024-12-31) — Excise Taxes: 44206000.00
CRON.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -1231000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Finished Goods: 13248000.00
CRON.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 5689000.00
CRON.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 3841000.00
CRON.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: -11202000.00
CRON.TO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: -780000.00
CRON.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 63415000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -63525000.00
CRON.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 55214000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Goodwill: 63453000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 74710000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 15469000.00
CRON.TO balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 15469000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 267976000.00
CRON.TO income_statement (annual, 2024-12-31) — Gross Profit: 25198000.00
CRON.TO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 16350000.00
CRON.TO income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
CRON.TO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 647000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 9000.00
CRON.TO income_statement (annual, 2024-12-31) — Interest Income: 52019000.00
CRON.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 52019000.00
CRON.TO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 0.00
CRON.TO balance_sheet (annual, 2024-12-31) — Inventory: 33149000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 1064063000.00
CRON.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 175149000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 0.00
CRON.TO balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 0.00
CRON.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 2813000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 0.00
CRON.TO balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 0.00
CRON.TO balance_sheet (annual, 2024-12-31) — Land And Improvements: 6389000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Loans Receivable: 618000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 993000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 993000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 0.00
CRON.TO balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 0.00
CRON.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 39428000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Minority Interest: 46919000.00
CRON.TO income_statement (annual, 2024-12-31) — Minority Interests: 1058000.00
CRON.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 5993000.00
CRON.TO cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
CRON.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
CRON.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -57859000.00
CRON.TO income_statement (annual, 2024-12-31) — Net Income: 41080000.00
CRON.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 41080000.00
CRON.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 40022000.00
CRON.TO income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 0.00
CRON.TO income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
CRON.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 41080000.00
CRON.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 41080000.00
CRON.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 40022000.00
CRON.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 40022000.00
CRON.TO cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -743000.00
CRON.TO income_statement (annual, 2024-12-31) — Net Interest Income: 52019000.00
CRON.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 185817000.00
CRON.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 52019000.00
CRON.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1231000.00
CRON.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -3507000.00
CRON.TO cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 25000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Net PPE: 134579000.00
CRON.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -12411000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 989353000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 2571000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 3564000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 2571000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 3564000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Non Current Note Receivables: 15526000.00
CRON.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: -59796000.00
CRON.TO income_statement (annual, 2024-12-31) — Normalized Income: 32934450.00
CRON.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 18843000.00
CRON.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -75285000.00
CRON.TO income_statement (annual, 2024-12-31) — Operating Income: -59549000.00
CRON.TO income_statement (annual, 2024-12-31) — Operating Revenue: 161821000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 382530780.00
CRON.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 6277000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 40000.00
CRON.TO balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 40000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -63525000.00
CRON.TO income_statement (annual, 2024-12-31) — Other Gand A: 46514000.00
CRON.TO income_statement (annual, 2024-12-31) — Other Income Expense: 44116000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 11257000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Other Investments: 2813000.00
CRON.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -6651000.00
CRON.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -301000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Other Properties: 1390000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Other Receivables: 5000000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
CRON.TO balance_sheet (annual, 2024-12-31) — Payables: 28813000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 48635000.00
CRON.TO income_statement (annual, 2024-12-31) — Pretax Income: 36586000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
CRON.TO income_statement (annual, 2024-12-31) — Provision For Doubtful Accounts: 0.00
CRON.TO cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 1032000.00
CRON.TO cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -743000.00
CRON.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
CRON.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -12411000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 5551000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Receivables: 29770000.00
CRON.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 86782000.00
CRON.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 9336000.00
CRON.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CRON.TO income_statement (annual, 2024-12-31) — Research And Development: 4229000.00
CRON.TO income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 630000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 457709000.00
CRON.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 8700000.00
CRON.TO cash_flow (annual, 2024-12-31) — Sale Of Business: 5993000.00
CRON.TO cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
CRON.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 185817000.00
CRON.TO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 21603000.00
CRON.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 76817000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Share Issued: 382530780.00
CRON.TO income_statement (annual, 2024-12-31) — Special Income Charges: -53832000.00
CRON.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 8700000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1064063000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 989353000.00
CRON.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 1437450.00
CRON.TO income_statement (annual, 2024-12-31) — Tax Provision: -3436000.00
CRON.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
CRON.TO balance_sheet (annual, 2024-12-31) — Total Assets: 1166312000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 1064063000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Total Debt: 2018000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1110982000.00
CRON.TO income_statement (annual, 2024-12-31) — Total Expenses: 177164000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 55330000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 230199000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 5630000.00
CRON.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -76529000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 11840000.00
CRON.TO income_statement (annual, 2024-12-31) — Total Unusual Items: 9583000.00
CRON.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 9583000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
CRON.TO balance_sheet (annual, 2024-12-31) — Work In Process: 14350000.00
CRON.TO balance_sheet (annual, 2024-12-31) — Working Capital: 886413000.00
CRON.TO income_statement (annual, 2024-12-31) — Write Off: 25650000.00
CRON.TO income_statement (quarterly, 2024-12-31) — Write Off: 0.00
CRON.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 17251000.00
CRON.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 32262000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 9499000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 18714000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 4952000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -133462000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 8089000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 306100000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.02
CRON.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 858805000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 191210000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -15356000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1817000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 669036000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 797819000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 837819000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -2930000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -55356000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2096000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1637000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -8878000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 4000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -1631000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: -1633000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -10511000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -60000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -2335000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 4000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -14537000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -3409000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -60382000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 669036000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1066403000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 37270000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 18528000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 22547000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 918581000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 977000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 977000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 33048000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2840000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 496000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2840000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 496000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 306100000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.02
CRON.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 6122000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Non Current: 611000.00
CRON.TO income_statement (quarterly, 2025-03-31) — EBIT: -3517000.00
CRON.TO income_statement (quarterly, 2025-03-31) — EBITDA: -677000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 0.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -604000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 797819000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Excise Taxes: 9636000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -2930000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 13451000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -17452000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 68000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 1632000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -66449000.00
CRON.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 11397000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Goodwill: 63268000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 73893000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 273967000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 13734000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 0.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 50000.00
CRON.TO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 12000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Interest Income: 9665000.00
CRON.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 9665000.00
CRON.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00